A pilot MRI study of organ specific hemosiderosis and functional correlation in Chinese patients with myelodysplasia and aplastic anemia with raised ferritin levels

Hematological Oncology

Volumn 26, Issue 4, 2008, Pages 225-228

  Au, Wy ^a   Lam, W W M ^e   Chu, W W C ^e   Tam, S ^a   Wong, W K ^a   Chan, H ^b   Law, M F ^c   Liu, H S Y ^d   Liang, R ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c TUEN MUN HOSPITAL   (Hong Kong)

^d PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aplastic anemia; Hemosiderosis; Myelodysplasia

Indexed keywords

DEFEROXAMINE; FERRITIN;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE FUNCTION TEST; FEMALE; FERRITIN BLOOD LEVEL; HEART EJECTION FRACTION; HEART FAILURE; HEART HEMOSIDEROSIS; HEPATOGRAPHY; HUMAN; IMAGE ANALYSIS; INCIDENCE; INSULIN RESISTANCE; IRON CHELATION; MALE; MYELODYSPLASTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RADIOCARDIOGRAPHY; TISSUE SPECIFICITY; ASIAN; BLOOD TRANSFUSION; CARDIOMYOPATHY; EVALUATION; HEART DISEASE; HEMOSIDEROSIS; METABOLISM; MIDDLE AGED; PILOT STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD TRANSFUSION; CARDIOMYOPATHIES; FEMALE; FERRITINS; HEART DISEASES; HEMOSIDEROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PANCREATIC DISEASES; PILOT PROJECTS;

EID: 58949095477     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.862     Document Type: Article

References (22)

1. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004; 127(3): 348-355.
2. Jabbour E, Kantarjian HM, Koller C, Taher A. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes. Cancer 2008; 112(5): 1069-1095.
3. He T, Kirk P, Firmin DN, et al. Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment. J. Cardiovasc Magn Reson 2008; 10(1): 11.
4. Au WY, Lam WWM, Chu W, et al. AT2* magnetic resonance imaging (MRI) study of pancreatic iron overload in thalassemia major. Haematologica 2007; 93(1): 116-119.
5. Lam WWM, Au WY, Chu WCW, Tam S, Ha SY. MRI assessment of the pituitary in thalassaemia major. J Neuro Imaging 2008; (in press).
6. Au WY, Lam WWM, Chu WWC, et al. A cross-sectional MRI assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong. Haematologica 2008; (in press).
7. Au WY, Lam WWM, Chu W, et al. A magnetic resonance imaging (MRI) study of iron overload in haemopoietic stem cell transplantation recipients with increased ferritin levels. Transplant Proceed 2007; 39(10): 3369-3374.
8. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22(23): 2171-2179.
9. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood 2006; 107(9): 3733-3737.
10. Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109(10): 4586-4588.
11. Malcovati L, Porta MG, Pascutto C, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 2005; 23(30): 7594-7603.
12. Takatoku M, Uchiyama T, Okamoto S, et al. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/ mortality. Eur J Haematol 2007; 78(6): 487-494.
13. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood. 2003; 101(11): 4632-4639.
14. Konen E, Ghoti H, Goitein O, et al. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique. Am J Hematol 2007; 82(11): 1013-1016.
15. Chacko J, Pennell DJ, Tanner MA, et al. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Br J Haematol 2007; 138(5): 587-593.
16. Lu JP, Hayashi K. Selective iron deposition in pancreatic islet B cells of transfusional iron-overloaded autopsy cases. Pathol Int 1994; 44(3): 194-199.
17. Issaragrisil S, Vannasaeng S, Piankijagum A. Glucose intolerance, hyperinsulinemia and insulin resistance in aplastic anemia. Metabolism 1989; 38(3): 204-207.
18. Kailin X, Yushu H, Qingchao W, Yuanbo L. Hyperinsulinemia accompanying hyperglycemia in Chinese patients with aplastic anemia. Am J Hematol 1997; 56(3): 151-154.
19. Oudit GY, Sun H, Trivieri MG, et al. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003; 9(9): 1187-1194.
20. Farmaki K, Angelopoulos N, Anagnostopoulos G, Gotsis E, Rombopoulos G, Tolis G. Effect of enhanced iron chelation therapy on glucose metabolism in patients with betathalassaemia major. Br J Haematol 2006; 134(4): 438-444.
21. Porter J, Galanello R, Saglio G, et al. Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol 2008; 80(2): 168-176.
22. Henter JI, Karlen J. Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemia. Blood 2007; 109(12): 5157-5159.